Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,013 | -631 | -366 | -124 | -969 |
| Depreciation Amortization | 62 | N/A | N/A | N/A | 18 |
| Other Working Capital | -83 | -25 | -4 | 14 | -17 |
| Other Operating Activity | 240 | 155 | 68 | -40 | 1,241 |
| Operating Cash Flow | $-794 | $-502 | $-301 | $-150 | $273 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 192 | 192 | 59 | N/A | N/A |
| Purchase Of Investment | -5 | -5 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -250 |
| Investing Cash Flow | $187 | $187 | $59 | $N/A | $-250 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 295 | N/A | N/A | N/A | N/A |
| Debt Issued | 25 | 25 | N/A | N/A | N/A |
| Debt Repayment | -47 | -22 | -17 | -10 | -2 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 25 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -3 |
| Other Financing Activity | 110 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $383 | $3 | $-17 | $-10 | $20 |
| Beginning Cash Position | 337 | 337 | 337 | 337 | 295 |
| End Cash Position | 112 | 25 | 77 | 177 | 337 |
| Net Cash Flow | $-225 | $-312 | $-260 | $-159 | $42 |
| Free Cash Flow | |||||
| Operating Cash Flow | -794 | -502 | -301 | -150 | 273 |
| Free Cash Flow | -794 | -502 | -301 | -150 | 273 |